The Pharma Data

JANUARY 19, 2021

A naturally occurring system for tuning CRISPR-Cas9 expressing in bacteria, identified in a study published in Cell , could have implications for gene editing therapies as well. In bacteria with unaltered tracr-L, levels of CRISPR-related genes were low. The authors found that tracr-L redirects Cas9 in S.

Bacteria 52

Bacteria Gene Editing Research RNA 52

pharmaphorum

MAY 7, 2021

CRISPR’s deal with Nkarta aims to create genetically engineered NK cells, which are harvested and used to create a bank of “off the shelf” cells that can administered to patients like a drug. Nkarta also gets a license to CRISPR gene editing to an unlimited number of its own NK cell therapy products.

Gene Editing 52

Gene Editing Gene Genetic Engineering DNA 52

The Pharma Data

OCTOBER 26, 2020

These mAbs are already of human origin and functionally optimized for high potency by the donor’s immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality.

Antibody 52

Antibody Genetic Engineering Development Clinical Trials 52

Roots Analysis

AUGUST 31, 2023

coli bacteria, as well as lambda bacteriophage, can adapt to the alterations in the composition of their nutrient medium. Several diseases are caused by sub-optimal gene expression or through uncoordinated or unsynchronized production of a gene product.

Gene 40

Gene Gene Therapy Gene Expression Regulation 40

Advarra

OCTOBER 10, 2024

Some have argued bacteria are developing antibiotic resistance faster than we can research, develop, test and approve new antibiotics. One possible solution to antibiotic resistance: bacteriophages (or phages), which are viruses that infect bacteria. Bacteriophages (phages for short) are viruses that infect bacteria.

Bacteria 52

Bacteria Genetics Genetic Engineering Gene 52